Efficacy and Safety Study of BLS_ILB_E710c for the Fertile Women With Cervical Intraepithelial Neoplasia(CIN3)

Inclusion Criteria:

* Pre-menopausal patients between age of 20 and 50.
* Patients with cervical intraepithelial neoplasia 3(CIN3).
* Only infection with HPV type 16.
* Patients with Capable of observation of all of lesions by Colposcopy biopsy.
* Be informed of the nature of the study and will give written informed consent.
* Be agree with contraception during study
* White Blood Cell Count(WBC) over 4thous/ul, Hemoglobin above over 9.0g/dL Platelet over 150thous/uL and ANC(Absolute Neutrophil Count) over 1,500 /mm\^3
* Normal for EKG(Electrocardiography)
* AST/ALT : 2.5 times less than normal range

Exclusion Criteria:

* Autoimmune Disease or Prohibited drug(Therapy) bring about immunosuppressive.
* Patient that has medical history of hypersensitivity about Food containing Lactic acid bacteria or Lactic acid bacteria medication.
* Patient with Acute illness(ex. Acute Appendicitis, Myocardial infarction, Hemorrhage, meningitis etc.)
* Investigational product within three months before the start of the drug administration to patients treated with other test drug.
* Patient with Chronic pancreatitis currently or Patients diagnosed with acute pancreatitis.
* Organopathy Patient with Inflammatory intestine·bowel disease, gastrointestinal tumors, ulcers, bleeding, perforation etc.
* Pregnant or lactating women
* Patient with HBV or HCV infection (except for Asymptomatic)
* Patient that Investigator judge
* Deemed inappropriate for researchers to judge the patient